Keating Financial Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Keating Financial Advisory Services's BMY Position: Q2 2026 in Review
Keating Financial Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2026, buying an estimated $19.4K and bringing the position to 3,379 shares worth $195K. The position accounts for 0.03% of the portfolio, ranked #357.
Keating Financial Advisory Services first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $766K in Q4 2025. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Keating Financial Advisory Services held 3,379 shares of Bristol-Myers Squibb worth $195K as of Q2 2026.
- Keating Financial Advisory Services bought 338 Bristol-Myers Squibb shares in Q2 2026, an estimated $19.4K.
- Bristol-Myers Squibb made up 0.03% of Keating Financial Advisory Services's portfolio in Q2 2026, its #357 holding.
- Keating Financial Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Keating Financial Advisory Services's Bristol-Myers Squibb position peaked at $766K in Q4 2025.
- 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.